https://www.pharmanow.live/latest-news/ideaya-biosciences-ide849-adc-phase-1-sclc-os-esmo-2026 2026-10-23T22:39:22+05:30 Pharma Now en 2026-10-23T00:00:00+05:30 IDEAYA Biosciences Achieves 17.4-Month Median OS with IDE849 ADC in Relapsed SCLC IDEAYA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/3fcbf73a-527e-4b76-86d0-b9ccf59f4ece/3e53b841-baf7-49c4-956f-970e3cd4a9bf.png https://www.pharmanow.live/latest-news/fda-biologics-guidance-documents-container-closure-blood-manufacturing-biosimilars-2026 2026-10-23T22:40:17+05:30 Pharma Now en 2026-10-23T00:00:00+05:30 FDA Issues Twelve Biologics Guidance Documents Covering Container Closure, Blood Manufacturing, and Biosimilars FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/3fcbf73a-527e-4b76-86d0-b9ccf59f4ece/b26eee9d-71f7-48b9-a159-690e6ceb188f.png https://www.pharmanow.live/latest-news/ama-ema-joint-guidance-bundibugyo-ebola-vaccine-development 2026-10-23T22:43:34+05:30 Pharma Now en 2026-10-23T00:00:00+05:30 AMA and EMA Issue Joint Guidance on Bundibugyo Ebola Vaccine Clinical Trial Requirements AMA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/3fcbf73a-527e-4b76-86d0-b9ccf59f4ece/33a1d3cb-3f33-4e48-be30-f65f33d6cbf2.png https://www.pharmanow.live/latest-news/mineralys-therapeutics-lorundrostat-phase-3-ckd-hypertension-asn-2026 2026-10-23T22:41:54+05:30 Pharma Now en 2026-10-23T00:00:00+05:30 Mineralys Therapeutics Achieves Phase 3 Albuminuria and Blood Pressure Data for Lorundrostat in CKD Patients Mineralys https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2ec9108a-7071-4170-a4cc-9f70c98266eb/1a5002ae-b79f-4667-b213-d085b4fb911e.png https://www.pharmanow.live/latest-news/merck-fda-traditional-approval-pembrolizumab-tmb-h-solid-tumors-13-mut-mb 2026-10-23T22:30:25+05:30 Pharma Now en 2026-10-23T00:00:00+05:30 Merck Gains Traditional FDA Approval for Pembrolizumab FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/2ec9108a-7071-4170-a4cc-9f70c98266eb/a6d48b4e-593d-46ca-b886-054f51ee489c.png https://www.pharmanow.live/latest-news/genentech-kras-targeting-breakthrough-oncology-manufacturing-challenges 2026-10-23T22:37:06+05:30 Pharma Now en 2026-10-23T00:00:00+05:30 Genentech Achieves KRAS Targeting Breakthrough, Raising New Oncology Manufacturing Challenges Genentech https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://gene.com/assets/content/tile_image/press-release.jpg https://www.pharmanow.live/latest-news/fda-launches-nain-initiative-cns-product-review-cber-cder-cdrh 2026-10-23T22:13:57+05:30 Pharma Now en 2026-10-23T00:00:00+05:30 FDA Launches NAIN Initiative to Coordinate CNS Product Review Across CBER FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/4b7fb076-5e59-4807-87a7-31008187ee56/14a236fc-93c9-4e2a-b0a2-dad70ae8b013.png https://www.pharmanow.live/latest-news/abbvie-lutikizumab-phase-3-intrepid-hiscr75-hidradenitis-suppurativa 2026-10-23T14:47:05+05:30 Pharma Now en 2026-10-22T00:00:00+05:30 AbbVie Achieves Phase 3 HiSCR75 Primary Endpoint for Lutikizumab AbbVie https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/abbvie-lutikizumab-phase-3-intrepid-hidradenitis-suppurativa-202620261023110541.webp https://www.pharmanow.live/latest-news/insmed-japan-approval-brinsupri-bronchiectasis 2026-10-23T11:02:37+05:30 Pharma Now en 2026-10-22T00:00:00+05:30 Insmed Wins Japan Approval for Brinsupri in Bronchiectasis Insmed https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/insmed-brinsupri-japan-approval-bronchiectasis-202620261023105918.webp https://www.pharmanow.live/latest-news/fda-accelerated-approval-ultomiris-igan 2026-10-23T10:50:30+05:30 Pharma Now en 2026-10-22T00:00:00+05:30 FDA Grants Ultomiris Accelerated Approval for IgA Nephropathy FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-ultomiris-accelerated-approval-igan-kidney-disease-202620261023104817.webp https://www.pharmanow.live/latest-news/novartis-cosentyx-ema-approval-polymyalgia-rheumatica 2026-10-23T10:42:47+05:30 Pharma Now en 2026-10-22T00:00:00+05:30 Novartis Wins EU Approval for Cosentyx in Polymyalgia Rheumatica Novartis https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/novartis-cosentyx-eu-approval-polymyalgia-rheumatica-202620261023103907.webp